Sphingosine‐1‐phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells

Authors:
  • YSYoshito Sadahira
    Yoshito Sadahira
  • FRFuqiang Ruan
    Fuqiang Ruan
  • SHSen-Itiroh Hakomori
    Sen-Itiroh Hakomori
  • YIYasuyuki Igarashi
    Yasuyuki Igarashi

Abstract
Sphingosine‐1‐phosphate (Sph‐1‐P), the initial product of sphingosine (Sph) catabolism, has been reported to inhibit motility of mouse melanoma B16/F1 and other types of cells at very low concentrations (10–100 nM). Sph‐1‐P (100 nM–1 μM) inhibited pseudopodium formation by blocking polymerization and reorganization of actin filaments in newly formed pseudopodia, and reduced F‐actin by ∼ 25% in F1 cells. A pyrene‐labeled actin nucleation assay revealed that Sph‐1‐P (100 nM) inhibits actin nucleation mediated by F1 cell plasma membranes. These results suggest that Sph‐1‐P interacts with molecules associated with actin nucleation to inhibit reorganization of pseudopodium formation and cell motility.

This publication has 27 references indexed in Scilit: